ReviewAmerican journal of clinical dermatology2023

Ruxolitinib Cream 1.5%: A Review in Mild to Moderate Atopic Dermatitis.

Sheridan M HoyPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.